𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck

✍ Scribed by Waun Ki Hong; Steven Schaefer; Brian Issell; Charles Cummings; Daniel Luedke; Richard Bromer; Stephanie Fofonoff; Joan D'Aoust; Stanley Shapshay; Janet Welch; Elizabeth Levin; Miriam Vincent; Charles Vaughan; Stuart Strong

Book ID
111697608
Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
412 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sequential methotrexate–5-fluorouracil t
Sequential methotrexate–5-fluorouracil treatment of squamous cell carcinoma of the head and neck
✍ Ulrik Ringborg; GΓ–Sta Ewert; Jan Kinnman; Per-Gotthard Lundqvist; Hans Strander πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 271 KB πŸ‘ 2 views

Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue. The frequency of objective tumor regression obtained was 64% (complete response + partial response) with 19% complete regression. In 20 not pr

A phase II trial of cisplatin and vinore
A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
✍ Enrique Espinosa; Pilar Zamora; Alfredo MillΓ‘; Serafin Morales; Raquel Molina; M πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv